Announcement
07 Sep 2018
In September 2018, the European Investment Bank (EIB) signed a loan agreement with Grifols SA to support its research and development of finding new plasma-derived protein therapies. The loan will be guaranteed by the European Fund for Strategic Investment (EFSI).
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
07 Sep 2018
Revocation date:
No revocation date
Updated: 07 Sep 2018
State loan
In force
The EIB's loan to Grifols SA signed on 7 September 2018 was issued under the European Fund for Strategic Investment (EFSI). The loan has a total value of EUR 85 million (approx. USD 98 mi...
Sign in to see more
Updated: 07 Sep 2018
State loan
In force
The loan agreement between the European Investment Bank (EIB) and Grifols SA was signed on 7 September 2018 and has a total value of EUR 85 million (approx. USD 98 million). The loan will...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.